Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "Aflac Cancer Center" found in our extensive news archives from over 250 global news sources.
In addition to our news stories we have dozens of PubMed Articles about Aflac Cancer Center for you to read. Along with our medical data and news we also list Aflac Cancer Center Clinical Trials, which are updated daily. BioPortfolio also has a large database of Aflac Cancer Center Companies for you to search.
SOURCE: Aflac DESCRIPTION:It’s a warm and fuzzy gift. It’s a keepsake collectable. But, most importantly, it’s a way for anyone and everyone to give from their hearts in the crusade against childhood cancer. That’s right. It’s that time of year for the annual Aflac Holiday Duck to make its debut in Macy’s department stores nationwide and via the company’s own website. All net proc...
SOURCE: Aflac DESCRIPTION:For Teryn Buster, the Macy’s Thanksgiving Day Parade started well before the holiday. In early November, Columbus-based insurer Aflac flew the 10-year-old, her mom and grandmother to New York City for a behind-the-scenes tour of the Macy’s Parade Studio and VIP access to “Balloonfest” to see up close the newest balloonicles (self-powered balloon vehicles). “We l...
SOURCE: Aflac DESCRIPTION:Childhood cancer receives less than 5 percent of the national funding that goes toward cancer research and treatment. To help make it a national priority, Aflac once again joined Curefest for Childhood Cancer at its annual event near the U.S. Capitol in Washington, D.C. Since 2011, thousands of people from more than 40 states have convened at Curefest to speak as one vo...
SOURCE: Aflac DESCRIPTION:By Marina Hutchinson | AP A plush, robotic duck may soon become a fixture in the world of children who have cancer — a social robot that can be silly, happy, angry, scared or sick just like them, and help them cope creatively with their illness through the power of play. The duck, developed by robotics expert Aaron Horowitz and his company, is undergoing testing and is ...
On January 11, 2018, The Intercept published an article entitled "Behind the Duck: Former Aflac Employees Allege Fraud and Abuse in Nearly Every Aspect Read more...
SOURCE: Aflac DESCRIPTION:It’s been a challenging year for 10-year-old Teryn Buster. But on November 3, her spirits were flying high — as the Macy’s Thanksgiving Day Parade balloons recently did — during a visit to Macy’s Parade Studio in Moonachie, New Jersey, headquarters of the world-famous parade. Inside this warehouse is where most of the parade’s balloons and floats are construct...
Guinness Asset Management LTD Has Lifted Aflac Position By $1.49 Million; Gofen & Glossberg Has Trimmed Teva Pharmaceutical Ind Adr Stake Guinness Asset Management Ltd increased Aflac Inc stake by 12.54% reported in 2017Q2 SEC filing. Guinness Asset Management Ltd acquired 19,320 shares as Aflac Inc 's stock rose 3.90%.
Aflac shareholders may, no later than April 16, 2018, move the Court for appointment as a lead plaintiff of the Class. If you purchased Read more...
SOURCE: Aflac DESCRIPTION:Not long ago, companies were counseled to stay out of politics and social causes; “stick to business and you won’t offend customers or potential customers,” was thought to be the best route. Things have changed, partly owing to the millennial generation’s preference to buy from and work at companies that are responsible (see tables below). With millennials compris...
(Rapamycin Press) Using nanostring and RNA-sequencing technologies researchers from the NYU School of Medicine, the Perlmutter Cancer Center, UT MD Anderson Cancer Center, and the University of Massachusetts Medical School identified mi R-24-3p as a potential novel marker of breast cancer metastases in breast cancer.
Yale Cancer Center has launched the Yale Center for Immuno-Oncology. The new center will build on YCC's international leadership in immunobiology, cancer immunology, and development of novel cancer immunotherapies. It is a partnership between YCC and the department of Immunobiology at Yale University.
(St. Joseph's Hospital and Medical Center) Research by Jue Wang, MD, at the University of Arizona Cancer Center at Dignity Health St. Joseph's Hospital and Medical Center on 'Delay in Diagnosis of Testicular Cancer in a Patient with Down Syndrome' was published in the October issue of Journal of Cancer and Therapeutic Science.
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Postdoctoral Fellowships in Cancer Prevention at MD Anderson Cancer Center .The University of Texas MD Anderson Cancer Center,Â Cancer Prevention Research Training Program (CPRTP) is now acceptingÂ applications for two … Continue reading → Cet article #jobs #li...
Igor F. Tsigelny, Ph.D., Co-founder and Chief Strategic Officer at CureMatch and research professor at University of California, San Diego, is a co-author of “Genomic landscape of cell-free DNA in patients with colorectal cancer” in Cancer Discovery along with group of colleagues from Duke University Medical Center, University of Texas MD Anderson Cancer Center, Massachusetts General Hospital ...
(University of Arizona Health Sciences) Genistein, a major compound in soy foods, might aid in the proper functioning of a gene that can malfunction to cause breast cancer. A UA Cancer Center team is exploring the gene's potential to treat a form of breast cancer and help prevent the disease.
(UT Southwestern Medical Center) UT Southwestern Simmons Cancer Center scientists next month will begin testing a digital nanosensor that lights up cancer tissue to see whether it can improve the accuracy of cancer surgeries, thereby reducing cancer recurrence and surgical morbidity.
Research by Jue Wang, MD, at the University of Arizona Cancer Center at Dignity Health St. Joseph's Hospital and Medical Center on "Delay in Diagnosis of Testicular Cancer in a Patient with Down Syndrome" was published in the October issue of Journal of Cancer and Therapeutic Science.
A new cancer treatment technology is one step closer to Salt Lake City. Today Huntsman Cancer Institute at the University of Utah announced a plan to add a proton therapy center to its Cancer Hospital.
(University of Utah) Huntsman Cancer Institute at the University of Utah has been awarded a $2.4 million, two-year grant from the National Cancer Institute to help continue its research in breast cancer researchers will use this new funding to serve as a Breast Cancer Patient-derived xenograft Development and Trials Center to research and test new drugs for breast cancer. This new Center is only o...
(UNC Lineberger Comprehensive Cancer Center) In a study published in the International Journal of Cancer, researchers from the UNC Lineberger Comprehensive Cancer Center analyzed health indicators for children born to young breast cancer survivors in North Carolina.
(University of Arizona Health Sciences) A team led by UA Cancer Center researchers Agnieszka Witkiewicz, MD, and Erik Knudsen, PhD, screened for drugs that could target triple-negative breast cancer tumors, producing several new therapeutic candidates for this difficult-to-treat cancer.
Tempus, a Chicago-based technology company focused on helping doctors personalize cancer care by collecting and analyzing large volumes of molecular and clinical data, and Vanderbilt-Ingram Cancer Center (VICC) have announced a new collaboration to improve outcomes for cancer patients. As part of the initial research project, Tempus will use its Tempus O platform to ingest ... Read More
(University of California - San Diego) Scientists and physicians at Moores Cancer Center at UC San Diego Health, in partnership with colleagues at MD Anderson Cancer Center in Texas, Johns Hopkins University in Maryland and elsewhere, have been awarded a $7 million grant over four years by Stand Up to Cancer (SU2C) to create a "dream team" to develop new ways to prevent pancreatic cancer -- one of...
(UT Southwestern Medical Center) Researchers at UT Southwestern's Simmons Cancer Center have shown that RAS molecules act in pairs, known as dimers, to cause cancer, findings that could help guide them to a treatment.
In breakthrough colon cancer research, scientists at Christiana Care Health System's Center for Translational Cancer Research of the Helen F. Graham Cancer Center & Research Institute have discovered that over-expression of HOXA4 and HOXA9 genes in colon cancer stem cells promotes cell replication and contributes to the overpopulation of stem cells that drives colon cancer development.